IntegraGen SA (EPA:ALINT)
France · Delayed Price · Currency is EUR 0.1510
+0.0005 (0.33%)
Jul 14, 2026, 9:13 AM CET
IntegraGen Market Cap
IntegraGen has a market cap or net worth of €992.5 thousand as of July 14, 2026. Its market cap has decreased by -43.64% in one year.
Market Cap
992.50K
Enterprise Value
181.89K
Revenue
5.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.15
Market Cap Chart
Since June 18, 2010, IntegraGen's market cap has decreased from 34.24M to 992.50K, a decrease of -97.10%. That is a compound annual growth rate of -19.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 992.50K | 12.71% |
| Dec 31, 2025 | 880.55K | -76.46% |
| Dec 31, 2024 | 3.74M | -36.97% |
| Dec 29, 2023 | 5.93M | -25.72% |
| Dec 30, 2022 | 7.99M | 8.73% |
| Dec 31, 2021 | 7.35M | -46.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 19.27M |
| Aelis Farma | 14.28M |
| Poxel | 10.96M |
| NFL Biosciences | 10.77M |
| Aton | 8.78M |
| Plant Advanced Technologies | 7.19M |
| Oncodesign Precision Medicine Société anonyme | 6.53M |
| TME Pharma | 6.31M |